User Tools

    To create and edit articles, please register and log-in

Main Menu : categories & index etc.

Main menu
Click categories to expand


A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing

This is an alphabetical index of all content pages.


Other categories

Utilities

Contact
Register
Sandbox

Also see

Importance Ratings
News
Legal
Donate/Sponsor
Curator's rationale
AI Policy



Twitter feed 𝕏



Feeds + s.e.o. etc.
rss / xml feed
sitemap file
A-Z listing (archived)


Indexed under : Medicine / Diseases / M - Q

Wikenigma - an Encyclopedia of Unknowns Wikenigma - an Encyclopedia of the Unknown

Macular degeneration

Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which results in blurred (or absent) vision in the centre of the visual field. It can affect one or both eyes.

It's characterised by a general degeneration of the eye's central photo-receptors (retina) and surrounding tissues. Some types develop over a number of years, others in a matter of weeks.

It's estimated that it affects more than 6 million people worldwide - and it's a leading cause of vision loss in people 50 years or older. Autopsy research has shown that around a third of people over 65 have some degree of AMD.

The factors which trigger the development of the disease are not known, but there may be genetic links. Exposure to toxins etc (e.g. smoking), nutritional factors, and cardiovascular disease are also under consideration. Oxidative stress, hypertension, obesity, and atherosclerosis may also be factors.

Currently, the etiology of AMD remains elusive. In addition to age, recognized risk factors include cigarette smoking and diet.
[…]
Among all identified potential environmental factors, only age, diet and smoking are agreed upon by all to increase the risk of AMD.

Source : Genetic factors of age-related macular degeneration [ Paywalled ] Progress in Retinal and Eye Research, Volume 23, Issue 2, Pages 229-249

It is a permanent condition. There are various injected-drug treatment options - some at the experimental stage - which can slow the progress of the disease, but most of the drugs work by inhibiting blood vessel development, and are not without possible side effects (example ref.).

For further technical details of AMD see :

Clinical Interventions in Aging 2017; 12: and :

The Macular Society


    Please share this page to help promote Wikenigma !

Dear reader : Do you have any suggestions for the site's content?

Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.

If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !


Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.

( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)

Automatic Translation

You are currently viewing an auto-translated version of Wikenigma

Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.

Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.

Show another (random) article

Further resources :

DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK DECEMBER 2023